216 related articles for article (PubMed ID: 6418228)
1. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition.
Sixma JJ; Sakariassen KS; Beeser-Visser NH; Ottenhof-Rovers M; Bolhuis PA
Blood; 1984 Jan; 63(1):128-39. PubMed ID: 6418228
[TBL] [Abstract][Full Text] [Related]
2. Adhesion of blood platelets to human arterial subendothelium: role of factor VIII-Von Willebrand factor.
Bolhuis PA; Sakariassen KS; Sixma JJ
Haemostasis; 1979; 8(3-5):312-23. PubMed ID: 315905
[TBL] [Abstract][Full Text] [Related]
3. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor in the vessel wall mediates platelet adherence.
Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
[TBL] [Abstract][Full Text] [Related]
6. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
7. Association between bleeding time and platelet adherence to artery subendothelium.
Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.
Turitto VT; Weiss HJ; Zimmerman TS; Sussman II
Blood; 1985 Apr; 65(4):823-31. PubMed ID: 3872140
[TBL] [Abstract][Full Text] [Related]
10. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence.
Sakariassen KS; Ottenhof-Rovers M; Sixma JJ
Blood; 1984 May; 63(5):996-103. PubMed ID: 6424741
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
[TBL] [Abstract][Full Text] [Related]
13. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
[TBL] [Abstract][Full Text] [Related]
14. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
Kao KJ; Pizzo SV; McKee PA
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
Jorieux S; de Romeuf C; Samor B; Goudemand M; Mazurier C
Thromb Haemost; 1987 Jun; 57(3):278-82. PubMed ID: 3116700
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
19. Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets.
Fernandez MF; Ginsberg MH; Ruggeri ZM; Batlle FJ; Zimmerman TS
Blood; 1982 Nov; 60(5):1132-8. PubMed ID: 6982084
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted blood.
Sakariassen KS; Nieuwenhuis HK; Sixma JJ
Br J Haematol; 1985 Mar; 59(3):459-70. PubMed ID: 3918560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
